To determine cocaine's toxicity in different organs, BALB/c mice were intraperitoneally injected daily for 15 days with either saline or cocaine: 10 mg/kg, 30 mg/kg, or 60 mg/kg. Cardiac function, hepatic pathophysiology, heart and liver apoptosis, and tumor necrosis factor (TNF-α) levels were analyzed. After administration of cocaine, cardiac function decreased. Inflammatory cell infiltration and eosinophilic contraction bands were visible in the hearts of mice treated with 60mg/kg cocaine. Moreover, histopathology demonstrated that cocaine caused hepatic necrosis. TdT-mediated dUTP nick end-labeling (TUNEL) staining and DNA ladder analysis indicated that cocaine caused apoptosis in both the heart and liver. Moreover, immunoassay showed that TNF-α levels significantly increased in the heart and liver with cocaine administration. However, our RT-PCR study showed that there was no significant difference in either the heart or liver in the levels of mRNA for TNF-α between cocaine-treated and saline control mice. The present study demonstrated that cocaine is toxic to multiple organs, and at low dose can induce hepatic damage without gross pathological injury to the heart. The results suggest that the liver is more sensitive than the heart to cocaine toxicity, and induction of apoptosis or TNF-α elevation may be a common mechanism responsible for cocaines toxicity.
Get full access to this article
View all access options for this article.
References
1.
KlonerRA, HaleS, AlkerK, RezkallaS.The effects of acute and chronic cocaine use on the heart. Circulation85:407–419, 1992.
2.
KnuepferMM, BranchCA, GanQ, FischerVW. Cocaine-induced myocardial ultrastructural alterations and cardiac output responses in rats. Exp Mol Pathol59:155–168, 1993.
3.
KarenSB, BillinghamME. The pathology and etiology of cocaine-induced heart disease. Arch Pathol Lab Med112:225–230, 1988.
4.
RothL, HarrisonRD, JamesBC, TobinT, RobertsSM. Cocaine hepatotoxicity: Influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology15:934–940, 1992.
5.
BoyerCS, PertersonDR. Hepatic biochemical changes as a result of acute cocaine administration in the mouse. Hepatology14:1209–1216, 1991.
6.
ThompsonML, ShusterL, ShawK.Cocaine-induced hepatic necrosis in mice: The role of cocaine metabolism. Biochem Pharmacol28:2385–2395, 1979.
7.
AokiK, OhmoriM, TakimotoM, OtaH, YoshidaT.Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species. Eur J Pharmacol336:43–49, 1997.
8.
DeviBG, ChanAWK. Cocaine-induced peroxidative stress in rat liver: Antioxidant enzymes and mitochondria. J Pharmacol Exp Ther279:359–366, 1996.
9.
VeinotJP, GattingerDA, FlissH.Early apoptosis in human myocardial infarcts. Hum Pathol28:485–492, 1997.
10.
FlissH, GattingerD.Apoptosis in ischemic and reperfused rat myocardium. Circ Res79:949–956, 1996.
11.
JamesTN, MartinE, St. WillisPW, LohrTO. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. Circulation93:1424–1438, 1996.
12.
RaySD, MumawVR, RajeRR, FarissMW. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J Pharmacol Exp Ther279:1470–1483, 1996.
13.
CascalesM, AlvarezA, GascoP, Fernandez-SimonL, SanzN, BoscaL.Cocaine-induced liver injury in mice elicits specific changes in DNA ploidy and induces programmed death of hepatocytes. Hepatology20:992–1001, 1994.
KumarA, ThotaV, DeeL, OlsonJ, UretzE, ParrilloJE. Tumor necrosis factor-α and interleukin-1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med183:949–958, 1996.
16.
WangJH, RedmondHP, WilliamR, WatsonG, Bouchier-HayesD.Role of lipopolysaccharide and tumor necrosis factor-α in induction of hepatocyte necrosis. Am J Physiol269:G297–G304, 1995.
17.
StamblerBS, KomamuraK, IharaT, ShannonRP. Acute intravenous cocaine causes transient depression followed by enhanced left ventricular function in conscious dogs. Circulation87:1687–1697, 1993.
18.
BermardsCM, CullenBF, PowersKM. Effect of chronic cocaine exposure on the hemodynamic response to vasopressors in sheep. J Trauma43:680–686, 1997.
19.
ArbeilleP, MaulikD, SalihagicA, LocatelliA, LansacJ, PlattJD. Effect of long-term cocaine administration to pregnant ewes on fetal hemodynamics, oxygenation, and growth. Obstet Gynecol90:795–802, 1997.
20.
WilkersonRD. Cardiovascular effects of cocaine in conscious dogs: Importance of fully functional autonomic and central nervous system. J Pharmacol Exp Ther246:466–471, 1988.
21.
WilkersonRD, Temesy-ArmosPN, FrakerTD. Pharmacokinetics and time-action profile of cocaine in dogs. In: ThadaniP, Ed. Cardiovascular Toxicity of Cocaine: Underlying Mechanisms. Bethesda, MD: National Institute on Drug Abuse, pp28–39, 1991.
22.
VirmaniR, RobinowitzM, SmialekJE, SmythDF. Cardiovascular effects of cocaine: An autopsy study of 40 patients. Am Heart J115:1068–1076, 1988.
23.
TurizzoV, RubioMC. Effects of cocaine on several adrenergic system parameters. Gen Pharmacol16:71–76, 1985.
24.
PellinenP, HonkakoshP, StenbackF, NiemitzM, AlhavaE, PelkonenO, LangMA, PasanenM.Cocaine N-demethylation and its metabolism-related hepatotoxicity can be prevented by P450 3A inhibitors. Eur J Pharmacol270:35–48, 1994.
25.
DellinenP, StenbackF, KojoA, HonkakoskiP, GelboinHV, PasanenM.Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine. Hepatology23:515–523, 1996.
26.
Ndikum-MofforFM, SchoebTR, RobertsSM. Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine. J Pharmacol Exp Ther284:413–419, 1998.
27.
WuYB, ShenML, GuGG, AndersonKM, OuDW. The effects of cocaine injections on mouse thymocyte population. Proc Soc Exp Biol Med214:173–179, 1997.
28.
MeldrumDR. Tumor necrosis factor in the heart. Am J Physiol274:R577–R595, 1998.
29.
MungerMA, JohsonB, AmberIJ, CallahanKS, GilbertE.Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idopathic dilated cardiomyopathy. Am J Cardiol77:723–727, 1996.
30.
IngDJ, ZangJ, DzauVJ, WebsterKA, BishopricNH. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide. Bale, and Bcl-x. Circ Res84:21–33, 1999.
31.
KrownKA, PageMT, NguyenC, ZechnerD, GutierrezV, ComstockKJ, GlembotskiCC, QuintanaPJE, SabbadiniRA. Tumor necrosis factor-α-induced apoptosis in cardiac myocytes: Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest98:2854–2865, 1996.
32.
ShenHM, KennedyJL, OuDW. Inhibition of cytokine release by cocaine. Int J Immunopharmacol16:295–300, 1994.
33.
WangY, HuangDS, WatsonRR. In vivo and in vitro cocaine modulation on production of cytokines in C57BL/6 mice. Life Sci54:401–411, 1994.
